Clinical Trial Detail

NCT ID NCT02795520
Title Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoTherapy Science, Inc.
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

myelodysplastic/myeloproliferative neoplasm

chronic myeloid leukemia

myelodysplastic syndrome

myeloproliferative neoplasm

Therapies

OTS167

Age Groups: senior adult

No variant requirements are available.